|
NAV1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.067400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.274000E-01 |
| Normal-vs-Stage2 |
3.130600E-01 |
| Normal-vs-Stage3 |
1.985380E-01 |
| Normal-vs-Stage4 |
6.474200E-01 |
| Stage1-vs-Stage2 |
1.337250E-01 |
| Stage1-vs-Stage3 |
9.096500E-02 |
| Stage1-vs-Stage4 |
5.000400E-01 |
| Stage2-vs-Stage3 |
7.308000E-01 |
| Stage2-vs-Stage4 |
9.907000E-01 |
| Stage3-vs-Stage4 |
8.038000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.022000E-01 |
| Normal-vs-AfricanAmerican |
7.568600E-01 |
| Normal-vs-Asian |
5.753000E-01 |
| Caucasian-vs-AfricanAmerican |
6.869400E-01 |
| Caucasian-vs-Asian |
3.886400E-01 |
| AfricanAmerican-vs-Asian |
6.745400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.537400E-01 |
| Normal-vs-Female |
3.143600E-02 |
| Male-vs-Female |
3.461400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.859400E-01 |
| Normal-vs-Extreme_Weight |
1.394590E-01 |
| Normal-vs-Obese |
3.200200E-01 |
| Normal-vs-Extreme_Obese |
2.191000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.149200E-01 |
| Normal_Weight-vs-Obese |
2.321800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.983000E-01 |
| Extreme_Weight-vs-Obese |
4.159700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.257000E-01 |
| Obese-vs-Extreme_Obese |
1.069990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.298010E-01 |
| Normal-vs-Age(41-60Yrs) |
6.067200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.423400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.591700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.574800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.793800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.043600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.727150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.43710000000275E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.059960E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.143800E-01 |
| Normal-VS-Type2 PRCC |
3.598500E-02 |
| Normal-VS-KIRP CIMP |
4.201800E-03 |
| Normal-VS-Unclassified PRCC |
1.798430E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.687600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.322100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.996000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.420200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.098700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.020400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.351000E-01 |
| Normal-vs-N1 |
1.565380E-01 |
| Normal-vs-N2 |
4.595800E-01 |
| N0-vs-N1 |
9.860400E-02 |
| N0-vs-N2 |
4.208600E-01 |
| N1-vs-N2 |
6.202400E-01 |
|
|
